AnimalBiome is a science-powered animal health company that provides direct-to-consumer microbiome testing for pets and designs supplements to support healthy gut microbiomes. The company uses genetic sequencing and an algorithm built from a proprietary reference database to characterize individual pets' microbiomes and generate actionable reports for veterinarians and pet parents. Recommendations include personalized changes in diet, prebiotics, macronutrient ratios, and other supplements to restore microbial balance. AnimalBiome also leverages its proprietary pet microbiome platform to design new microbial cocktails and supplements aimed at manipulating and supporting healthy microbiomes. Led by co-founder and CEO Carlton Osborne and co-founder and Chief Science Officer Holly Ganz, the company focuses on cats and dogs, including those with chronic digestive disorders and skin conditions. Founded in 2016 and based in Oakland, Calif., AnimalBiome intends to use recent funding to accelerate growth and expand its product pipeline. AnimalBiome develops gut health tests and personalized diet, nutrition and lifestyle recommendations for companion animals based on genetic sequencing of bacteria in their microbiomes. The company sells restoration supplements branded DoggyBiome and KittyBiome that aim to support bowel movements, maintain normal stools, and soothe the intestinal tract. AnimalBiome plans to use new funding to advance gut health research and to further develop its restoration supplements for dogs and cats. Its product approach combines testing with personalized recommendations and nutritional products to monitor and improve pet health. The company originated from researchers at the University of California–Davis and Berkeley and was founded in 2016. Leadership recently shifted as Holly Ganz moved into the chief science officer role and Carlton Osborne was named CEO.

Total raised

$10M

Funding rounds

2

Latest round

Series A

Latest activity

Aug 2021